Allocations
Great Rock Capital, an asset-focused commercial finance company specialising in middle market lending, has completed a GBP25 million secured term loan for Zacky & Sons Poultry, a vertically integrated grower, processor, and distributor of premium poultry products.
In addition, Great Rock Capital partnered with GemCap Solutions, an innovative lending firm that provides senior-secured, commercial asset-based loans, which provided a GBP16 million revolving loan.
The capital will enable Zacky & Sons to refinance existing senior indebtedness and fund capital expenditures to expand its production facilities to support the company’s growth.
“We are excited about our partnership with Great Rock
Gide has advised ENYO Pharma on its EUR40 million Series B round of financing from US and European investors.
ENYO Pharma is a clinical stage biotech company developing innovative drug candidates by mimicking virus strategies to modulate host cellular functions. This very significant funding will enable the company to finance the two first Phase II clinical trials of its EYP001 asset in both chronic HBV and NASH. A second asset is also expected to enter the clinic by 2019.
This round was led by OrbiMed, followed by Andera Partners and Bpifrance Large Venture as new shareholders. Existing shareholders Sofinnova
Target Global, a Berlin-based international venture capital fund with USD600m in assets under management, is launching a dedicated fund to invest in next-generation mobility and transportation.
Its unique evergreen structure means that, unlike traditional VC funds which have a fixed end-point, this one will run indefinitely. The fund can deploy up to USD300 million in capital, providing investors with a long-term interest in disruptive changes across the entire mobility spectrum. The primary targets for investment will be European and Israeli startups that focus on innovation and technology in automotive, private & public transportation, logistics & delivery and related cross-services.
Venture investing platform Portfolia Funds has launched its sixth fund – The Portfolia FemTech Fund – which will invest exclusively in emerging technologies, products and services focused on improving women’s health and wellness.
Frost and Sullivan recently published a report stating that FemTech will be a USD50 billion market by 2025. Spurred on by rapid innovation in the health space, a positive regulatory environment and the fact that women now control 80 per cent of healthcare decisions in the US household, FemTech is predicted to be the next big disruptor in the global healthcare market. While the benefits of FemTech
Marqeta, an open-API card issuing platform, has raised USD45 million in new funding in a round led by ICONIQ Capital, with participation from Goldman Sachs and existing investors, bringing the firm’s total funding to USD116 million.
“Marqeta is the clear market leader in modern card issuing, and we’re thrilled to be part of their already phenomenal growth story,” says Will Griffith, partner at ICONIQ Capital. “They have the most advanced card issuing technology in the category, and they have assembled an extraordinary team of industry leaders.”
Marqeta will leverage the investment, along with the USD25 million it took in
Linden Capital Partners (Linden), a Chicago-based healthcare private equity firm, has completed its investment in Solara Medical Supplies.
Headquartered in Chula Vista, California, Solara is a leading direct-to-patient supplier of advanced diabetic devices, including continuous glucose monitors, insulin pumps and other supplies for the intensively managed diabetic. Linden Operating Partner, Ron Labrum, and Linden advisor, Keith Crawford, have been named Chairman and CEO, respectively.
“Linden looks forward to building upon Solara’s commitment to patient service, manufacturers and payors,” says Labrum, who brings a wealth of experience to Solara with prior roles as Executive Vice President at Cardinal Health, President
Ropes & Gray has advised Hamilton Lane on Hamilton Lane Strategic Opportunities Fund IV. The Fund announced its final close with USD900 million in commitments on 5 June, substantially above the initial target.
The Fund is focused on making credit-oriented investments with consistent cash yield, shorter duration and attractive risk-adjusted returns. Fund IV is comprised of a diverse set of institutions, including pension funds, insurance companies, endowments/foundations and high net worth individuals, including a number of existing as well as new investors from Asia, the Middle East, Europe and North and South America.
Fund IV represents the fourth dedicated
Intelliflo, a UK technology platform for financial advisers, has been acquired by Invesco. Intelliflo has been owned by HgCapital, a European private equity investor in B2B technology companies, since 2013.
Since its inception in 2004, Intelliflo has experienced rapid growth and has become the No1 technology platform for financial advisers in the UK, successfully supporting the business of approximately 30 per cent of UK advisers. Intelliflo’s Intelligent Office (iO) software platform is the backbone of the UK wealth sector, assisting financial advisers with client relationship management, financial planning, client reporting, portfolio valuation and provision of advisor-led automated advice.
“Invesco
Hailo, a company developing a proprietary chip for deep learning on edge devices, has completed a USD12.5 million Series A round.
The company’s investors include Ourcrowd.com, Maniv Mobility, the Drive accelerator fund: Next Gear; as well as angel investors, Hailo Chairman Zohar Zisapel and Delek Motors CEO Gil Agmon. The company will use the funding to further develop its deep learning processor, which will deliver datacenter processing capacity to edge devices. This latest funding round brings the total raised to date by the Tel Aviv-based company to USD16 million.
Hailo’s breakthrough deep learning processor, whose initial samples are expected
Sentinel Capital Partners, a private equity firm that invests in promising companies at the lower end of the mid-market, has sold RotoMetrics, a provider of high precision rotary cutting tool solutions. Terms of the deal have not been disclosed.
Headquartered in St Louis, Missouri, RotoMetrics provides made-to-order precision rotary cutting dies and engineered tooling for web converting and printing applications. These products are critical components in the production of a wide array of tags, labels, and packaging items used in the consumer goods, healthcare, electrical component, automotive, and industrial markets. RotoMetrics has an established global footprint of ten sales offices
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
